首页> 外文期刊>Journal of Periodontology >Clinical evaluation of wound healing following multiple exposures to enamel matrix protein derivative in the treatment of intrabony periodontal defects.
【24h】

Clinical evaluation of wound healing following multiple exposures to enamel matrix protein derivative in the treatment of intrabony periodontal defects.

机译:多次接触牙釉质基质蛋白衍生物治疗骨内牙周缺损后伤口愈合的临床评估。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Multiple exposures to enamel matrix protein derivative (EMD) during periodontal therapy have been shown to be safe for the patient. The purpose of this study was to clinically determine if an altered course of wound healing would occur after multiple exposures to EMD in the treatment of intrabony defects. A secondary aim was to assess the efficacy of EMD in probing depth reduction and clinical attachment level gain. METHODS: Thirty-two systemically healthy patients (18 females, 14 males, 33 to 69 years old) who were being treated for moderate to advanced periodontal disease were selected for the study. Surgical procedures involving 2 sites were separated by at least 8 weeks, and wound healing comparisons were made between the first and second procedure. Patients were given a diary card the day of surgery, which consisted of questions concerning the presence and severity of headaches, root hypersensitivity, tooth pain, swelling, and itching. Patients were also examined at postoperative visits to clinically assess wound healing and discuss responses to the questionnaire. Soft tissue measurements were taken the day of surgery and 6 months postoperatively to ascertain probing depth reduction (PD) and gains in clinical attachment levels (CAL). RESULTS: The results revealed no clinically detectable reaction that could not be attributed to normal postoperative sequelae. There were no differences in reported symptoms between patient gender, first and second procedures, or intrabony and non-intrabony defects. Smokers were found to have a statistically significantly higher incidence of severe symptoms in root hypersensitivity, tooth pain, and swelling compared to non-smokers (n = 21). The mean probing depth reduction was 3.8 +/- 1.5 mm (2 to 9 mm), while the mean clinical attachment level gain was 2.8 +/- 1.7 mm (0 to 8 mm). CONCLUSIONS: The findings of this study demonstrate that EMD is a clinically safe product to use in the treatment of periodontal defects and that multiple uses do not have a negative impact on periodontal wound healing. In addition, a statistically significant gain in clinical attachment and reduction in probing depth were demonstrated.
机译:背景:在牙周治疗期间多次接触牙釉质基质蛋白衍生物(EMD)已显示对患者安全。这项研究的目的是临床确定在多次治疗骨内缺损的EMD后是否会改变伤口愈合的过程。第二个目的是评估EMD在探查深度减少和临床依附水平增加方面的功效。方法:选择接受中度至晚期牙周疾病治疗的32例全身健康的患者(女性18例,男性14例,年龄33至69岁)。将涉及2个部位的外科手术间隔至少8周,并在第一个和第二个手术之间进行伤口愈合比较。在手术当天给患者一张日记卡,其中包括有关头痛的存在和严重程度,牙根过敏,牙齿疼痛,肿胀和瘙痒的问题。术后还对患者进行了检查,以临床评估伤口愈合情况并讨论对问卷的回答。在手术当天和术后6个月进行软组织测量,以确定探查深度减少(PD)和临床附着水平(CAL)升高。结果:结果显示没有临床可检测到的反应,不能归因于正常的术后后遗症。患者性别,第一次和第二次手术,骨内和非内脏缺陷之间的报道症状无差异。与不吸烟者相比,吸烟者在根部过敏,牙齿疼痛和肿胀方面的严重症状发生率在统计学上显着更高(n = 21)。平均探测深度减少为3.8 +/- 1.5毫米(2至9毫米),而平均临床附着水平增加为2.8 +/- 1.7毫米(0至8毫米)。结论:这项研究的结果表明,EMD是一种可用于治疗牙周缺损的临床安全产品,多次使用对牙周伤口愈合没有负面影响。此外,还证明了临床依从性和探测深度的减少具有统计学意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号